Tiziana Life Sciences Ltd (TLSA)

USD 0.99

(0.02%)

Annual Income Statements

(In USD)
Breakdown 2022 2021 2020 2019 2018 2017
Revenue - - - - - -
Cost of Revenue 51 Thousand 141 Thousand 89.76 Thousand 250.04 Thousand - -
Gross Profit -51 Thousand -141 Thousand -89.76 Thousand -250.04 Thousand - -
Operating Expenses 14.58 Million 27.37 Million 32.27 Million 10.19 Million 9.44 Million 11.14 Million
Selling, General and Administrative Expenses 1.63 Million 855 Thousand 14.02 Million 6.2 Million 4.41 Million -
Research and Development Expenses 12.95 Million 13.2 Million 6.36 Million 3.81 Million 5.24 Million 6.31 Million
Other Expenses -804 Thousand 13.31 Million 11.88 Million 6.37 Million 3.48 Million 3.57 Million
Cost and Expenses 14.58 Million 27.37 Million 32.27 Million 10.19 Million 9.44 Million 11.14 Million
Operating Income -14.58 Million -27.37 Million -29.74 Million -10.19 Million -9.44 Million -11.14 Million
Interest Expense 7000.00 176 Thousand 339.34 Thousand 94.4 Thousand 11.42 Thousand 12.16 Thousand
Income Tax Expense - -3.24 Million -2.34 Million -708.02 Thousand -1.85 Million -2 Million
Earnings before Tax -15.39 Million -26.65 Million -30.07 Million -10.28 Million -9.45 Million -11.15 Million
Net Income -16.2 Million -23.41 Million -27.73 Million -9.57 Million -7.6 Million -9.14 Million
Earnings Per Share Basic -0.16 -0.24 -0.16 -0.07 -0.06 -0.03
Earnings Per Share Diluted -0.16 -0.24 -0.16 -0.07 -0.06 -0.03
Weighted Average Shares Outstanding 101.52 Million 97.93 Million 169.06 Million 136.48 Million 127.55 Million 266 Million
Weighted Average Shares Outstanding (Diluted) 101.52 Million 97.93 Million 169.06 Million 136.48 Million 127.55 Million 266 Million
Gross Margin - - - - - -
EBIT Margin - - - - - -
Profit Margin - - - - - -
EBITDA -15.33 Million -26.34 Million -32.16 Million -9.93 Million -9.43 Million -11.12 Million
Earnings Before Tax Margin - - - - - -

Income Statement Charts